Our Science
The overarching focus of the Wahl laboratory is to improve treatments for patients with glioblastoma, the most common and aggressive type of brain tumor. The group is especially interested in how abnormal metabolism confers radiation resistance in glioblastoma and using drug-radiation combinations to overcome this resistance.